Epithelioma Complicating Lupus Erythematosus

由 Ryan, Charles
出版 1947

Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment

由 Aggarwal, Rahul, Ryan, Charles J.
出版 2011

Hard Problems Need “Soft” Science: Integrating Quality of Life into Treatment Decision Making

由 Morgans, Alicia K., Ryan, Charles J.
發表在 Eur Urol (2019)

DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities

由 Dhawan, Mallika, Ryan, Charles J., Ashworth, Alan
發表在 Oncologist (2016)

A review of prostate cancer treatment impact on the CNS and cognitive function

由 Ryan, Charles, Wefel, Jeffrey S., Morgans, Alicia K.
發表在 Prostate Cancer Prostatic Dis (2019)

Low Self-Control, Social Learning, and Texting while Driving

由 Meldrum, Ryan Charles, Boman, John H., Back, Sinchul
發表在 Am J Crim Justice (2018)

Routes and mechanisms of extracellular vesicle uptake

由 Mulcahy, Laura Ann, Pink, Ryan Charles, Carter, David Raul Francisco
出版 2014

Prostate cancer in the era of “Omic” medicine: recognizing the importance of DNA damage repair pathways

由 Kornberg, Zachary, Chou, Jonathan, Feng, Felix Y., Ryan, Charles J.
發表在 Ann Transl Med (2018)

Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data

由 Ryan, Charles J., Saylor, Philip J., Everly, Jason J., Sartor, Oliver
出版 2014

At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials

由 Borno, Hala T., Zhang, Li, Siegel, Adam, Chang, Emily, Ryan, Charles J.
發表在 Oncologist (2018)

Royal Society Scientific Meeting: Extracellular vesicles in the tumour microenvironment

由 Pink, Ryan Charles, Elmusrati, Areeg A., Lambert, Daniel, Carter, David Raul Francisco
發表在 Philos Trans R Soc Lond B Biol Sci (2018)

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs

由 Layton, Jodi L., Lewis, Brian, Ryan, Charles, Beer, Tomasz M., Sartor, Oliver
發表在 Oncologist (2018)

Diet and Lifestyle Considerations for Patients with Prostate Cancer

由 Zuniga, Kyle B., Chan, June M., Ryan, Charles J., Kenfield, Stacey A.
發表在 Urol Oncol (2019)

Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility

由 Crawford, E. David, Shore, Neal D., Petrylak, Daniel P., Higano, Celestia S., Ryan, Charles J.
發表在 Ther Adv Med Oncol (2017)

Differential utilization of medical versus surgical androgen deprivation therapy for metastatic prostate cancer

由 Borno, Hala T., Lichtensztajn, Daphne Y., Gomez, Scarlett L., Palmer, Nynikka R., Ryan, Charles J.
發表在 Cancer (2018)

Brain Activity, Low Self-Control, and Delinquency: An fMRI Study of At-Risk Adolescents

由 Meldrum, Ryan Charles, Trucco, Elisa M., Cope, Lora M., Zucker, Robert A., Heitzeg, Mary M.
發表在 J Crim Justice (2017)

Triple Aberrant Prostate Cancer (TAPC) - Aggregate role of aberrations in TP53, PTEN and RB1 on ETS gene fusions and prognosis in metastatic castrate resistant prostate cancer

由 Watson, Allison P, Shabaneh, Ashraf, Wang, Jinhua, Dehm, Scott M, Rao, Arpit, Ryan, Charles J
發表在 Am J Clin Exp Urol (2020)

Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer’s Disease

由 Carr, Jessie S., Bonham, Luke W., Morgans, Alicia K., Ryan, Charles J., Yokoyama, Jennifer S., Geier, Ethan G.
發表在 Front Neurosci (2018)

Pseudogenes: Pseudo-functional or key regulators in health and disease?

由 Pink, Ryan Charles, Wicks, Kate, Caley, Daniel Paul, Punch, Emma Kathleen, Jacobs, Laura, Francisco Carter, David Raul
出版 2011

HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer

由 Almassi, Nima, Reichard, Chad, Li, Jianbo, Russell, Carly, Perry, Jaselle, Ryan, Charles J., Friedlander, Terence, Sharifi, Nima
發表在 JAMA Oncol (2017)